Form 4: OPKO Health CEO Phillip Frost Acquires 100,000 Shares in Open Market Purchase

OPKO Health's CEO and Chairman, Phillip Frost, acquired 100,000 shares of common stock at an average price of $1.6198 per share on November 14, 2024.

Summary

• Phillip Frost, CEO and Chairman of OPKO Health, acquired 100,000 shares of OPKO common stock on November 14, 2024.
• The shares were purchased at a weighted average price of $1.6198, with individual transactions ranging from $1.615 to $1.6199.
• Following the transaction, Mr. Frost directly owns 3,568,951 shares and indirectly owns 211,612,405 shares through Frost Gamma Investments Trust and 30,127,177 shares through Frost Nevada Investments Trust.
• Frost Gamma Investments Trust is a 10% owner of OPKO Health and is controlled by Phillip Frost as trustee.
• Frost Nevada Investments Trust is also controlled by Phillip Frost as trustee.

Sentiment

Score: 7

Explanation: The document reflects a positive sentiment due to the CEO's purchase of shares, which is generally seen as a sign of confidence. However, it's a routine transaction and not a major event.

Positives

• The CEO's purchase of shares could be seen as a positive signal of confidence in the company's future prospects.
• The purchase increases the CEO's stake in the company, aligning his interests with those of other shareholders.

Industry Context

Insider buying is often seen as a positive sign in the market, suggesting that those with the most knowledge of the company's prospects are optimistic about its future. This purchase by the CEO could be interpreted as a bullish signal for OPKO Health.

Comparison to Industry Standards

• Insider trading activity is closely monitored by investors and regulators. Large purchases by key executives like the CEO are often seen as a positive signal, especially when compared to industry peers where insider selling might be more prevalent.
• While not directly comparable, similar purchases by CEOs in the biotech and healthcare sector are often viewed as a sign of confidence in the company's pipeline and future growth prospects.

Stakeholder Impact

• The share purchase could positively impact shareholder confidence.
• The purchase aligns the CEO's interests more closely with those of shareholders.

Key Dates

Keywords

OPKO Health, Phillip Frost, insider trading, share purchase, common stock, Frost Gamma Investments Trust, Frost Nevada Investments Trust, SEC Form 4